Expert Consensus
Copyright ©The Author(s) 2021.
World J Clin Cases. Mar 26, 2021; 9(9): 2110-2122
Published online Mar 26, 2021. doi: 10.12998/wjcc.v9.i9.2110
Table 3 Development of transdermal patch[14]
Classification
Characteristic
First-generation transdermal patchThe drug should have suitable properties (highly potency, low molecular weight and lipophilic) to solve the problem of low oral bioavailability, to reduce the frequency of drug administration or to achieve stable drug administration
Second-generation transdermal patchThis generation of patch can promote and improve the percutaneous absorption of small molecule drugs by means of a chemical penetration enhancer, ion introduction or ultrasound
Third-generation transdermal patchThese patches help to promote percutaneous absorption of macromolecules, including therapeutic proteins and vaccines